✦ LIBER ✦

P272 Infliximab for moderate to severe ulcerative colitis: Short-and long-term therapy and predictors of response

✍ Scribed by Y. Ron; H. Yanai; M. Ben Yehoyada; E. Meirovithz; L. Yahav; D. Yeshurun; E. Santo; I. Dotan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa2032 Infliximab for Moderate to Severe

✍ Ron, Yulia; Yanai, Henit; Yehoyada, Merav Ben; Meirovithz, Elhanan; Yahav, Lior; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

P187 - Predictors of response to inflixi

✍ O. García-Bosch; M. Aceituno; I. Ordás; J. Etchevers; M. Sans; F. Feu; E. Ricart 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 80 KB

Su1229 Predictors of Response to Inflixi

✍ Vaughn, Byron P.; Pleet, Julie; Cheifetz, Adam S.; Moss, Alan C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 164 KB

409 Adalimumab for Ulcerative Colitis Pa

✍ Carlos Taxonera; Jesús Estellés; Ignacio Blanco; Olga Merino; Ignacio Marin-Jime 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Infliximab in severe ulcerative colitis:

✍ A. KOHN; M. DAPERNO; A. ARMUZZI; M. CAPPELLO; L. BIANCONE; A. ORLANDO; A. VISCID 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Su1402 Short and Long Term Outcomes of S

✍ Minami, Naoki; Yoshino, Takuya; Matsuura, Minoru; Nakase, Hiroshi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 338 KB